NexImmune, Inc.

NASDAQ:NEXI

0.25 (USD) • At close November 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -32.344-62.506-50.902-29.866-20.547-12.834
Depreciation & Amortization 1.0250.9950.870.6190.4360.205
Deferred Income Tax 1,041.0580-3.2920.44200
Stock Based Compensation 3.5545.875.981.2171.5341.206
Change In Working Capital -4.8783.9290.655-0.089-0.8420.304
Accounts Receivables 000000
Inventory 000000
Accounts Payables -1.0411.387-1.0030.7020.2350.192
Other Working Capital -3.8372.5421.657-0.792-1.0770.112
Other Non Cash Items -1,039.8440.5210.9041.2720.0021.424
Operating Cash Flow -31.43-51.191-45.785-26.405-19.416-11.118
Investing Activities:
Investments In Property Plant And Equipment -0.049-1.255-2.35-0.865-1.246-0.938
Acquisitions Net 0.0040.081-32.065000
Purchases Of Investments 0-21.51-90.4570-7.074-17.613
Sales Maturities Of Investments 073391.00617.7315.949
Other Investing Activites 4.22881.93132.0650.080.01-0.04
Investing Cash Flow -0.04450.316-53.8070.2229.421-12.642
Financing Activities:
Debt Repayment 000000
Common Stock Issued 05.145114.7220.00718.7839.188
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 00.03310.17822.09809.188
Financing Cash Flow 05.179124.88822.08518.7659.18
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -31.4754.30325.295-4.0988.77-14.58
Cash At End Of Period 3.22234.69730.3945.0999.1960.426